RNXT
RenovoRx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.39
+0.84%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -1.03x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.75x
Liquidity & coverage
- Current ratio
- 5.74x
- Quick ratio
- 5.53x
- Cash ratio
- 5.03x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $8.9M
Cash & dividend
- FCF / debt
- -46.09x
- Cash flow / debt
- -45.81x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026